Risperidone under renewed scrutiny as use in aged care rises

The review is part of the PBAC’s ongoing monitoring of the use of antipsychotics in aged care facilities.

The PBAC is planning a fresh review of antipsychotic prescribing in aged care after a report found the use of risperidone to treat dementia symptoms was on the rise.

The committee asked its Drug Utilisation Sub-Committee (DUSC) to monitor use of the drugs last year, having rejected a recommendation from the Royal Commission into Aged Care Quality and Safety to restrict antipsychotic initiation to geriatricians and psychiatrists.